5-fluorouracil-induced Raynaud's phenomenon [3]

European Journal of Cancer

Volumn 34, Issue 12, 1998, Pages 1983-

  Papamichael, D ^a   Amft, N ^a   Slevin, M L ^a   D'Cruz, D ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; FLUOROURACIL; FOLINIC ACID;

ADULT; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOTOXICITY; ERYTHROCYTE SEDIMENTATION RATE; FINGER BLOOD FLOW; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIA; LETTER; LIVER METASTASIS; MALE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RECTUM CARCINOMA; VASOSPASM;

ANTINEOPLASTIC AGENTS; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; RAYNAUD DISEASE;

EID: 0032213471     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00184-1     Document Type: Letter

References (9)

1. 1. Pottage A, Holt S, Ludgate S, et al. Fluorouracil cardiotoxicity. Br Med J 1978, 6112, 547.
2. 2. Labianca R, Beretta G, Clerici M, et al. Cardiac toxicity of 5-fluorouracil: a study on 1083 patients. Tumori 1982, 68, 505-510.
3. 3. Freeman NJ, Costanza ME. 5-Fluorouracil-associated cardiotoxicity. Cancer 1988, 61, 36-45.
4. 4. Werquin S, Kacet S, Caron J, et al. Raynaud's phenomenon and finger necrosis after treatment of ovarian seminoma with bleomycin, vinblastine and 5-fluorouracil. Ann Cardiol Angeiol 1987, 36, 409-412.
5. 5. Bleiberg H, Conroy T, Paillot B, et al. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 1997, 33, 1216-1220.
6. 6. Mosseri M, Fingert HJ, Varticovski L, et al. In vitro evidence that myocardial ischaemia resulting from 5FU chemotherapy is due to protein kinase C mediated vasoconstriction of vascular smooth muscle. Cancer Res 1993, 53, 3028-3033.
7. 7. Cwikiel M, Persson SU, Larsson H, et al. Changes of blood viscosity in patients treated with 5-fluorouracil - a link to cardiotoxicity? Acta Oncol 1995, 34, 83-85.
8. 8. Kuzel T, Esparaz B, Green D, et al. Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 1990, 65, 885-889.
9. 9. Esklisson J, Albertsson M, Mercke C, et al. Adverse cardiac effects during induction chemotherapy treatment with cisplatin and 5-fluorouracil. Radiother Oncol 1988, 13, 41-46.